Diagnostic performance of direct immunofluorescence microscopy studies by biopsy sites in autoimmune subepidermal blistering dermatoses: a prospective study von Haefliger, S., Sitaru, S., Cazzaniga, S., Rammlmair, A., Feldmeyer, L., Horn, M.P., Borradori, L.

Volltext

Business model configurations and performance: A qualitative comparative analysis in Formula One racing, 2005-2013 von Aversa, Paolo, Furnari, Santi, Haefliger, Stefan

Volltext

OA10.04 Tarlatamab with a PD-L1 Inhibitor as First-Line Maintenance after Chemo-immunotherapy for ES-SCLC: DeLLphi-303 Phase 1b Study von Lau, S., Ahn, M.-J., Moskovitz, M., Pogorzelski, M., Haefliger, S., Paulson, K.G., Parkes, A., Zhang, Y., Hamidi, A., Wermke, M.

Volltext

Primary liver cancers display divergent epimutator phenotypes in localized and metastatic disease von Rourke, C.O., Haefliger, S., Haegele, J., Burmeister, K., Matter, M., Andersen, J.

Volltext

PS-173 - Primary liver cancers display divergent epimutator phenotypes in localized and metastatic disease von Rourke, C.O., Haefliger, S., Haegele, J., Burmeister, K., Matter, M., Andersen, J.

Volltext

MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis von Dorn, P., Holer, L., Lardinois, D., Dutly, A., Karenovics, W., Habicht, J., Lutz, J.A., Gelpke, H., Opitz, I., Haefliger, S., König, D., Früh, M., Addeo, A., Vonder Mühll-Schill, C., Bettini, A., Scheibe, B., Savic Prince, S., Guckenberger, M., Finazzi, T., Rothschild, S.I., Mauti, L.A.

Volltext

Initiating private-collective innovation: The fragility of knowledge sharing von Gächter, Simon, von Krogh, Georg, Haefliger, Stefan

Volltext

575P TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumours: Dose escalation part of a multicenter open-label phase I trial (SAKK 65/16) von Hess, D., Colombo, I., Haefliger, S., Bastian, S., Rabaglio, M., Metaxas, Y., Eckhardt, K., Kopp, C., Hayoz, S., Mueller-Schoell, A., Kloft, C., Sessa, C., Stathis, A., Joerger, M.

Volltext

P14.05 Phase 2, Study of Iovance Autologous Tumor Infiltrating Lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) In Patients With Solid Tumors von Gettinger, S., Kluger, H., Schoenfeld, A., Warner, A. Betof, He, K., Sukari, A., Thomas, S., Doger, B., Lee, S., Haefliger, S., Goldberg, Z., Cacovean, A., Fiaz, R., Chen, G., Jagasia, M., Finckenstein, F. Graf, Fardis, M., Jimeno, A.

Volltext

187TiP Phase II, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumours von Gettinger, S., Kluger, H., Schoenfeld, A., Warner, A. Betof, He, K., Sukari, A., Thomas, S.S., de Spéville, B. Doger, Lee, S., Haefliger, S., Goldberg, Z., Cacovean, A., Fiaz, R., Chen, G., Jagasia, M., Finckenstein, F. Graf, Fardis, M., Jimeno, A.

Volltext

Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers von Pradervand, S., Freundler, N., Gosztonyi, B., Roncoroni, L., Achermann, R., Schwenk, T., de Fraipont, G., Garessus, J., Haefliger, S., Leichtle, A.B., Kiessling, M.K., Mueller-Focke, T., Krebs, F.S., Zoete, V., Tsantoulis, P., Michielin, O., Britschgi, C., Wicki, A.

Volltext

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland von Samyshkin, Yevgeniy, Schlunegger, Michael, Haefliger, Susan, Ledderhose, Sabine, Radford, Matthew

Volltext

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients von Bibert, Stéphanie, Guex, Nicolas, Lourenco, Joao, Brahier, Thomas, Papadimitriou-Olivgeris, Matthaios, Damonti, Lauro, Manuel, Oriol, Liechti, Robin, Götz, Lou, Tschopp, Jonathan, Quinodoz, Mathieu, Vollenweider, Peter, Pagani, Jean-Luc, Oddo, Mauro, Hügli, Olivier, Lamoth, Frédéric, Erard, Véronique, Voide, Cathy, Delorenzi, Mauro, Rufer, Nathalie, Candotti, Fabio, Rivolta, Carlo, Boillat-Blanco, Noémie, Bochud, Pierre-Yves

Volltext

Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences von Burren, Oliver S., Dhindsa, Ryan S., Deevi, Sri V. V., Wen, Sean, Nag, Abhishek, Mitchell, Jonathan, Hu, Fengyuan, Loesch, Douglas P., Smith, Katherine R., Razdan, Neetu, Olsson, Henric, Platt, Adam, Vitsios, Dimitrios, Wu, Qiang, Codd, Veryan, Nelson, Christopher P., Samani, Nilesh J., March, Ruth E., Wasilewski, Sebastian, Carss, Keren, Fabre, Margarete, Wang, Quanli, Pangalos, Menelas N., Petrovski, Slavé

Volltext

Communal Resources in Open Source Software Development von Spaeth, Sebastian, Haefliger, Stefan, von Krogh, Georg, Renzl, Birgit

Volltext

Metric Spaces of Non-Positive Curvature von Bridson, Martin R, Häfliger, André

Volltext

A Process View of Business Model Innovation von Fallahi, Sara

Volltext bestellen

Knowledge Reuse in Open Source Software: An Exploratory Study of 15 Open Source Projects von von Krogh, G., Spaeth, S., Haefliger, S.

Volltext

Regulation and Self-Regulation of Team Learning and Innovation Activities von Annosi, Maria Carmela

Volltext bestellen

Supplementary Material for: Complete Response on Larotrectinib in NTRK2-Fusion positive NSCLC von L., Frehner, S., Haefliger, F., Cerciello, T., Grob, S., Schmid

Volltext bestellen